108127-91-9 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
4-Amino-1,2-dihydroisoquinolin-1-one hydrochloride is used as a key building block for the synthesis of various pharmaceuticals, contributing to the development of drugs that address a range of health conditions.
Used in Neurological and Psychiatric Disorders Treatment:
In the pharmaceutical industry, 4-Amino-1,2-dihydroisoquinolin-1-one hydrochloride is utilized as an active pharmaceutical ingredient for the development of drugs aimed at treating neurological and psychiatric disorders, due to its potential therapeutic effects on the central nervous system.
Used in Cancer Treatment Research:
4-Amino-1,2-dihydroisoquinolin-1-one hydrochloride is employed as a subject of research in oncology for its potential role in inhibiting the growth of certain types of cancer cells, offering a promising avenue for the development of novel cancer therapeutics.
Used in Anti-Inflammatory and Analgesic Applications:
In the field of pain management and inflammation control, 4-Amino-1,2-dihydroisoquinolin-1-one hydrochloride is studied for its potential anti-inflammatory and analgesic properties, which could lead to the creation of new medications for these purposes.
Check Digit Verification of cas no
The CAS Registry Mumber 108127-91-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,8,1,2 and 7 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 108127-91:
(8*1)+(7*0)+(6*8)+(5*1)+(4*2)+(3*7)+(2*9)+(1*1)=109
109 % 10 = 9
So 108127-91-9 is a valid CAS Registry Number.
108127-91-9Relevant academic research and scientific papers
Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process
-
, (2008/06/13)
The invention is selected, novel, and known analogs of isoquinolinones of the formula and pharmaceutically acceptable salts thereof; novel pharmaceutical compositions; and a method for enhancing the lethal effects for tumor cells to treatment having DNA damaging activity such as ionizing radiation or with chemotherapeutic agents.
